<DOC>
	<DOCNO>NCT00017147</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . O6-benzylguanine may help carmustine kill tumor cell make tumor cell sensitive drug . It yet know whether radiation therapy carmustine effective without O6-benzylguanine . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy plus carmustine without O6-benzylguanine treat patient newly diagnose glioblastoma multiforme gliosarcoma .</brief_summary>
	<brief_title>S0001 RT Carmustine With Without O6BG Patients With New Glioblastoma Multiforme Gliosarcoma</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall survival , failure-free survival , progression-free survival patient newly diagnose glioblastoma multiforme gliosarcoma treat radiotherapy carmustine without O6-benzylguanine . - Compare frequency severity toxic effect regimens patient . - Correlate survival patient expression O6-alkylguanine-DNA alkyltransferase . OUTLINE : This randomize study . Patients stratify accord age ( 50 vs 50 ) , prior surgery ( biopsy v resection ) , Zubrod performance status ( 0-1 v 2 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo radiotherapy daily 5 day week 7 week total 34 fraction . Patients also receive chemotherapy comprise O6-benzylguanine IV 1 hour follow 6 hour later carmustine IV 1 hour day 1 radiotherapy . Chemotherapy repeat every 6 week maximum 7 course absence disease progression unacceptable toxicity . - Arm II : Patients undergo radiotherapy arm I . Patients receive carmustine IV arm I . Patients follow week 48 , every 4 month 1 year , every 6 month 4 year . PROJECTED ACCRUAL : A total 375 patient accrue study within 5 year .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Gliosarcoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Eye Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>O ( 6 ) -benzylguanine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm glioblastoma multiforme gliosarcoma Biopsy surgical resection within past 28 day MRI* gadolinium perform registration Patients undergo simple biopsy require preoperative MRI* gadolinium No 2 noncontiguous tumor site base T2weighted MRI ( 3 dimension ) * No prior radiotherapydelivered cephalad interspace seventh cervical first thoracic vertebral body NOTE : *If MRI medically feasible , patient may CT scan contrast PATIENT CHARACTERISTICS : Age : 18 Performance status : Zubrod 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 3,000/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 8 g/dL Hepatic : Bilirubin great 2 time upper limit normal ( ULN ) SGOT/SGPT great 2 time ULN Alkaline phosphatase great 2 time ULN PT/PTT great 1.2 time ULN Renal : Not specify Cardiac : No severe cardiac disease , include follow : Uncontrolled arrhythmias conduction defect Major problem edema ( e.g. , residual swell legs deep vein thrombosis ) Recent coronary artery disease Poorly control hypertension ( i.e. , diastolic blood pressure great 110 mm Hg and/or systolic blood pressure great 180 mm Hg ) Pulmonary : DLCO least 70 % predict No severe pulmonary disease Other : HIV negative No severe Cushing 's syndrome No known allergy study drug No major psychiatric illness No poorly control diabetes complicate steroid treatment No medical illness adequately control would preclude study participation No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer currently complete remission Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy No concurrent antitumor chemotherapy Endocrine therapy : No concurrent hormonal therapy except postmenopausal estrogen replacement therapy Corticosteroids stable decrease dose tumor edema allow Radiotherapy : See Disease Characteristics No prior radiotherapy No concurrent radiotherapy ( include intensitymodulated radiotherapy ) index lesion ( ) Surgery : See Disease Characteristics No concurrent antitumor surgery Other : No concurrent investigational drug No concurrent antineoplastic drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>